Schedule 13G
MDWD Schedule 13G filing by T. Rowe Price Associates
T. Rowe Price Associates reported beneficial ownership of 614.5K shares, representing 12% of MediWound Ltd. in this filing.
FiledNov 14, 2025
Ownership dateSep 30, 2025
Reported shares614.5K
Reported ownership12%
Ownership details
Voting and dispositive power reported in the filing
These figures describe the reporting filer’s disclosed voting and investment authority. They should be read together with the reported share count and percentage.
Sole voting power
601.6K
Shared voting power
614.5K
Sole dispositive power
614.5K
Shared dispositive power
614.5K
Price context
Price dates alongside the ownership filing
Price data provides market context around the disclosure. It does not identify the filer’s actual transaction price.
Close near filing date$18.25as of Nov 14, 2025
Latest tracked price$14.19as of Aug 5, 2026
Source
Original filing and accession
Use the SEC filing as the primary source when you need the complete disclosure, footnotes, exhibits, or reporting-person details.
- Reporting filer
- T. Rowe Price Associates
- CIK
- CIK0000080255
- Accession
- 0000080255-25-000818
- Form
- Schedule 13G
Read the filing in context